Aditum Bio Announces Formation of Motric Bio, Focused on Spasticity Associated with Neurological Injuries and Disease

OAKLAND, Calif.: OAKLAND, Calif., Nov. 15, 2021 /PRNewswire/ -- Aditum Bio, the biotech investment firm co-founded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research (NIBR) Dr. Mark Fishman, today announced the formation of Motric Bio, a portfolio company developing a...

Click to view original post